| Manager | Title | Age | Since |
|---|---|---|---|
Ola Holmlund
CEO | Chief Executive Officer | 57 | 2017-12-31 |
Jan Holmbäck
CTO | Chief Tech/Sci/R&D Officer | 69 | 2009-12-31 |
Charlotta Ekman
DFI | Director of Finance/CFO | 45 | 2022-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Ola Flink
CHM | Chairman | 82 | 2016-12-31 |
| Chairman | 46 | 2019-12-31 | |
Gunilla Lundmark
BRD | Director/Board Member | 63 | 2019-05-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -98.73% | - | - | 92.63K | |
| +2.16% | +3.17% | +43.57% | +160.28% | 1,013B | |
| -0.07% | +4.45% | +53.50% | +48.95% | 574B | |
| -0.08% | -0.08% | +17.37% | +62.66% | 397B | |
| +0.77% | +0.77% | +21.19% | +15.95% | 324B | |
| +0.85% | +0.18% | +24.50% | +15.93% | 280B | |
| +2.10% | +4.92% | +25.30% | +34.79% | 273B | |
| +4.84% | +2.45% | +21.33% | +61.85% | 182B | |
| -0.19% | -0.46% | -45.32% | -48.23% | 194B | |
| +3.61% | -2.56% | +15.16% | +61.12% | 151B | |
| Average | +1.40% | +2.19% | +19.62% | +45.92% | 376.52B | |
| Weighted average by Cap. | +1.35% | +2.65% | +29.45% | +72.50% |
Employees
4
Sector
Pharmaceuticals
